# Eagle Pharmaceuticals Board Extends Limited Duration Stockholder Rights Plan
Canonical URL: https://biopharmsignal.com/news/EGRX/eagle-pharmaceuticals-board-extends-limited-duration-stockholder-rights-plan
Ticker: EGRX
Company: Eagle Pharmaceuticals
Source: Eagle Pharmaceuticals
Published: 2025-10-30 10:50 EST
Original Source URL: https://investor.eagleus.com
## Summary

WOODCLIFF LAKE, N.J., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Eagle Pharmaceuticals, Inc. (OTCMKTS: EGRX) (the “Company” or “Eagle”) today announced that its Board of Directors (the “Board”) has adopted an amendment (the “Amendment”) to its existing limited duration stockholder rights plan (as amended,

## Article Body
WOODCLIFF LAKE, N.J., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Eagle Pharmaceuticals, Inc. (OTCMKTS: EGRX) (the “Company” or “Eagle”) today announced that its Board of Directors (the “Board”) has adopted an amendment (the “Amendment”) to its existing limited duration stockholder rights plan (as amended,
## Recent Company News
- 2026-01-14 15:21 EST — [Eagle Pharmaceuticals Announces Divestiture of Barhemsys](https://biopharmsignal.com/news/EGRX/eagle-pharmaceuticals-announces-divestiture-of-barhemsys) — Source: Eagle Pharmaceuticals
- 2025-10-30 10:50 EST — [Eagle Pharmaceuticals Board Extends Limited Duration Stockholder Rights Plan](https://biopharmsignal.com/news/EGRX/eagle-pharmaceuticals-board-extends-limited-duration-stockholder-rights-plan) — Source: Eagle Pharmaceuticals
- 2025-10-21 20:05 EST — [Eagle Pharmaceuticals Announces Results of 2025 Annual Meeting of Stockholders](https://biopharmsignal.com/news/EGRX/eagle-pharmaceuticals-announces-results-of-2025-annual-meeting-of-stockholders) — Source: Eagle Pharmaceuticals
- 2025-10-15 20:30 EST — [Eagle Pharmaceuticals Announces Availability of Unaudited Second Quarter 2025 Financial Statements](https://biopharmsignal.com/news/EGRX/eagle-pharmaceuticals-announces-availability-of-unaudited-second-quarter-2025-financial-statements) — Source: Eagle Pharmaceuticals
- 2025-10-06 23:30 EST — [Eagle Pharmaceuticals Announces Availability of Unaudited First Quarter 2025 Financial Statements](https://biopharmsignal.com/news/EGRX/eagle-pharmaceuticals-announces-availability-of-unaudited-first-quarter-2025-financial-statements) — Source: Eagle Pharmaceuticals
## Related News
- 2026-07-29 14:05 EST — CAPR — [The Lancet Publishes HOPE-3 Data for Capricor Therapeutics’ Deramiocel in Duchenne Muscular Dystrophy](https://biopharmsignal.com/news/CAPR/the-lancet-publishes-hope-3-data-for-capricor-therapeutics-deramiocel-in-duchenn-9e6e6bd9)
- 2026-07-29 13:00 EST — ENLV — [Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones](https://biopharmsignal.com/news/ENLV/enlivex-management-to-host-webinar-to-discuss-capital-strategy-rain-protocol-tre-5921a627)
- 2026-07-29 12:30 EST — PRGO — [Perrigo to Present at the Canaccord 46th Annual Growth Conference](https://biopharmsignal.com/news/PRGO/perrigo-to-present-at-the-canaccord-46th-annual-growth-conference-40431922)
- 2026-07-29 12:30 EST — LIXT — [NOMAD Announces Operational Deployment of Two Mobile Battery Systems by DSO Electric Cooperative](https://biopharmsignal.com/news/LIXT/nomad-announces-operational-deployment-of-two-mobile-battery-systems-by-dso-elec-7fc12a2c)
- 2026-07-29 12:30 EST — RNXT — [RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET](https://biopharmsignal.com/news/RNXT/renovorx-to-host-second-quarter-2026-financial-results-and-business-highlights-c-8bed10ec)